https://openbell.ai/ 2026-09-29T12:54:36.451Z hourly 1.0 https://openbell.ai/support 2026-09-29T12:54:36.451Z monthly 0.7 https://openbell.ai/privacy 2026-09-29T12:54:36.451Z monthly 0.5 https://openbell.ai/terms 2026-09-29T12:54:36.451Z monthly 0.5 https://openbell.ai/feed.json 2026-09-29T12:54:36.451Z hourly 0.8 https://openbell.ai/news/META:1790686426437 2026-09-29T12:53:46.437Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jim Cramer Says Meta Must Be Seen as an ‘Enterprise Company’ as Muse AI Could Drive an '18 Times Multiple' to 24-25x Jim Cramer emphasized that Meta Platforms Inc. (NASDAQ: META) should be regarded as an 'enterprise company' due to its new Muse AI technology, which he believes could increase the company's stock valuation multiple from 18 times to 24-25 times. He highlighted a significant executive transition, with the CEO of MongoDB Inc. leaving to lead Meta's new division, indicating a strategic shift towards enterprise software. Currently, META's stock is trading 1.14% higher in pre-market, but has seen a 3.78% decline over the past year, though it is up 8.41% year-to-date. https://openbell.ai/news/SSTI:1790686359762 2026-09-29T12:52:39.762Z daily 0.9 https://cdn.brandfetch.io/SSTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud SoundThinking shares are trading higher after the company announced it will be acquired by Transom Capital. openbell Financial News https://openbell.ai/news/NIVF:1790686325052 2026-09-29T12:52:05.052Z daily 0.9 https://cdn.brandfetch.io/NIVF/w/400/h/400?c=1idopYfmtR7ZKg8QMud NewGenIvf Group shares are trading lower after the company announced it priced its $1.25 million public offering of 17,857,143 share or pre-funded warrants at $0.07 per share. openbell Financial News https://openbell.ai/news/VSXY:1790686287619 2026-09-29T12:51:27.619Z daily 0.9 https://cdn.brandfetch.io/VSXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Victoria's Secret, Raises Price Target to $100 Wells Fargo analyst Ike Boruchow has maintained an Overweight rating on Victoria's Secret (NYSE: VSXY) and increased the price target from $90 to $100. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/BKYI:1790686254828 2026-09-29T12:50:54.828Z daily 0.9 https://cdn.brandfetch.io/BKYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BIO-key shares are trading higher after the company announced a strategic partnership with Al Majlis Group to bring its identity security platform to government and private sector organizations across the UAE and Saudi Arabia. openbell Financial News https://openbell.ai/news/ETHUSD:1790686123252 2026-09-29T12:48:43.252Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Bitcoin-and-Ethereum.jpg?width=250&height=187 Bitcoin ETF Inflows Surge but ETH Still Outperforms: What Is Going On? Bitcoin (BTC) has seen an 8% increase over the past month, while Ethereum (ETH) has outperformed with an 11% rise. Spot Bitcoin ETFs recorded $2.77 billion in net inflows from September 17 to September 27, contributing to Bitcoin's recovery above $85,000. Meanwhile, Ethereum's spot trading volume was 300% that of Bitcoin on September 29, indicating strong investor interest, although ETF flows for Ethereum have been mixed recently. https://openbell.ai/news/MAIN:1790686122473 2026-09-29T12:48:42.473Z daily 0.9 https://cdn.brandfetch.io/MAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Upgrades Main Street Capital to Overweight, Raises Price Target to $60 Wells Fargo analyst Finian O'Shea has upgraded Main Street Capital (NYSE: MAIN) from Equal-Weight to Overweight. The price target for the stock has been raised from $55 to $60. https://openbell.ai/news/MBRX:1790686024022 2026-09-29T12:47:04.022Z daily 0.9 https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moleculin Biotech Completes Patient Enrollment In Part A Of Its Pivotal Phase 2/3 MIRACLE Study Of Annamycin In Combination With Cytarabine To Treat Adults With Relapsed Or Refractory Acute Myeloid Leukemia Moleculin Biotech, Inc. (NASDAQ: MBRX) has completed enrollment in Part A of its pivotal Phase 2/3 MIRACLE trial, with 89 subjects enrolled for the study of Annamycin in combination with cytarabine for treating adults with relapsed or refractory acute myeloid leukemia. An additional subject is currently in screening, and the company anticipates a comprehensive data readout in the first quarter of 2027. The rapid enrollment highlights the significant unmet need in this patient population and the engagement from clinical sites. https://openbell.ai/news/FSK:1790685931096 2026-09-29T12:45:31.096Z daily 0.9 https://cdn.brandfetch.io/FSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Downgrades FS KKR Capital to Underweight, Maintains Price Target to $10 Wells Fargo analyst Finian O'Shea has downgraded FS KKR Capital (NYSE: FSK) from Equal-Weight to Underweight. The price target for the stock remains unchanged at $10. https://openbell.ai/news/W:1790685849837 2026-09-29T12:44:09.837Z daily 0.9 https://cdn.brandfetch.io/W/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Maintains Outperform on Wayfair, Raises Price Target to $110 Mizuho analyst David Bellinger has maintained an Outperform rating on Wayfair (NYSE: W) and increased the price target from $90 to $110. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/SPY:1790685759967 2026-09-29T12:42:39.967Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Redbook Retail Sales Index Up 8.2% YoY For Week Ended 9/26/26 openbell Financial News https://openbell.ai/news/XNDU:1790685513277 2026-09-29T12:38:33.277Z daily 0.9 https://cdn.brandfetch.io/XNDU/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Initiates Coverage On Xanadu Quantum with Outperform Rating, Announces Price Target of C$16 RBC Capital analyst Paul Treiber has initiated coverage on Xanadu Quantum (TSX: XNDU) with an Outperform rating. The firm has set a price target of C$16 for the company's stock. https://openbell.ai/news/T:1790685512913 2026-09-29T12:38:32.913Z daily 0.9 https://cdn.brandfetch.io/T/w/400/h/400?c=1idopYfmtR7ZKg8QMud Corning To Provide Fiber, Cable Under $3B Agreement To AT&T To Expand Its Network AT&T has signed a multi-year agreement with Corning Incorporated valued at over $3 billion. Under this agreement, Corning will supply fiber and cable to support AT&T's network expansion, aimed at providing faster and more reliable internet services to a larger customer base, driven by increasing data demand from AI technologies. https://openbell.ai/news/ZS:1790685479901 2026-09-29T12:37:59.901Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Zscaler, Raises Price Target to $220 Barclays analyst Saket Kalia has maintained an Overweight rating on Zscaler (NASDAQ: ZS) and increased the price target from $200 to $220. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/CMI:1790685462370 2026-09-29T12:37:42.370Z daily 0.9 https://cdn.brandfetch.io/CMI/w/400/h/400?c=1idopYfmtR7ZKg8QMud EquipmentShare.com Enters Multi-Year Fleet Agreement With Cummins As Rental And Distribution Channel Partner EquipmentShare has entered a multi-year fleet agreement with Cummins to enhance its capabilities in providing temporary power solutions amid rising electricity demand in the U.S. The partnership will focus on utilizing Cummins' C1400N6C gas generator set, which offers 1400 - 1750 kVA of power, positioning EquipmentShare as a key player in the temporary power and energy storage market. This strategy aims to reduce energy costs for contractors by 50% to 80% compared to traditional mobile power sources. https://openbell.ai/news/FCEL:1790685455998 2026-09-29T12:37:35.998Z daily 0.9 https://cdn.brandfetch.io/FCEL/w/400/h/400?c=1idopYfmtR7ZKg8QMud FuelCell Energy shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $24 price target. openbell Financial News https://openbell.ai/news/FBLG:1790685364418 2026-09-29T12:36:04.418Z daily 0.9 https://cdn.brandfetch.io/FBLG/w/400/h/400?c=1idopYfmtR7ZKg8QMud FibroBiologics Receives European Patent Titled Methods Of Enhancing Fibroblast Therapeutic Activity FibroBiologics, Inc. (Nasdaq: FBLG) has been granted European Patent No. 3568465 by the European Patent Office, which focuses on methods to enhance the therapeutic activity of fibroblasts. This patent includes techniques for improving fibroblast efficacy in cell and tissue regeneration by using platelet-rich plasma and specific cytokines, such as FGF-alpha and FGF-beta. The patent also addresses claims related to angiogenesis and spinal disc regeneration. https://openbell.ai/news/BKR:1790685341332 2026-09-29T12:35:41.332Z daily 0.9 https://cdn.brandfetch.io/BKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Reinstates Buy on Baker Hughes, Announces $71 Price Target Goldman Sachs analyst Neil Mehta has reinstated a Buy rating on Baker Hughes (NASDAQ: BKR) and set a price target of $71 for the stock. This move indicates a positive outlook for the company in the market. https://openbell.ai/news/LLY:1790685251701 2026-09-29T12:34:11.701Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/South-San-Francisco--Ca--Usa---Feb-23--2.jpg?width=250&height=187 Eli Lilly Launches Global Push to Expand Weight-Loss and Diabetes Drug Access in Lower Income Countries Eli Lilly launched the Lilly Change the Course Commitment, a global initiative aimed at increasing access to diabetes and obesity treatments in low- and middle-income countries (LMICs) by 2040. Currently, only one in four people in LMICs can access its medicines compared to high-income countries. The initiative focuses on clinical development, medicine registration in more LMICs, and strengthening local health systems. Additionally, Lilly's oral treatment Foundayo has gained traction, with one-third of new GLP-1 patients choosing it, and the company is constructing a $6.5 billion manufacturing plant in Houston. https://openbell.ai/news/LNG:1790685250040 2026-09-29T12:34:10.040Z daily 0.9 https://cdn.brandfetch.io/LNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cheniere Energy Enters Supply Agreement With Petrobras To Provide ~0.8Mtpa Of LNG On A Free-On-Board Basis For 22 Years openbell Financial News https://openbell.ai/news/IQV:1790685238689 2026-09-29T12:33:58.689Z daily 0.9 https://cdn.brandfetch.io/IQV/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $319 RBC Capital analyst Ryan Halsted has maintained an 'Outperform' rating on IQVIA Holdings (NYSE: IQV) and increased the price target from $247 to $319. https://openbell.ai/news/SAIC:1790685144223 2026-09-29T12:32:24.223Z daily 0.9 https://cdn.brandfetch.io/SAIC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SAIC Announces $742M Five-Year Recompete Contract To Support U.S. Customs And Border Protection Systems openbell Financial News https://openbell.ai/news/RZLT:1790685141900 2026-09-29T12:32:21.900Z daily 0.9 https://cdn.brandfetch.io/RZLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Craig-Hallum Upgrades Rezolute to Buy, Raises Price Target to $7 Craig-Hallum analyst Albert Lowe has upgraded Rezolute (NASDAQ: RZLT) from a Hold to a Buy rating. The price target for the stock has been raised from $4 to $7. https://openbell.ai/news/AGPU:1790685081924 2026-09-29T12:31:21.924Z daily 0.9 https://cdn.brandfetch.io/AGPU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Axe Compute Receives Over $266M In New AI Infrastructure Contracts Since Aug. 17 Axe Compute Inc (NASDAQ: AGPU) has secured over $266 million in new AI infrastructure contracts and received more than $184 million in customer prepayments since August 17, 2026. These prepayments indicate strong demand and momentum as the company converts contracted commitments into revenue. https://openbell.ai/news/VOYG:1790684995706 2026-09-29T12:29:55.706Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/VoyagerLinkping--stergtland--Sweden--05-.jpg?width=250&height=187 Voyager Stock Rises After Formalizing Anduril Partnership Voyager Technologies Inc. (NYSE: VOYG) announced a strategic partnership with Anduril Industries to enhance the development and production of advanced weapon systems and missile defense technologies, leading to a 4.28% increase in its stock price to $34.60. The partnership formalizes an existing contract worth over $60 million for critical technologies, including solid rocket motors. Both companies aim to scale production capabilities, with Voyager's facilities in Colorado expected to support 15,000 to 20,000 propulsion systems per month once fully operational. https://openbell.ai/news/SOUN:1790684826199 2026-09-29T12:27:06.199Z daily 0.9 https://cdn.brandfetch.io/SOUN/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: SoundHound CEO's Winning Formula: 'AI Resolves What It Can, Humans Handle What They Should' SoundHound AI (NASDAQ: SOUN) is undergoing significant expansion, highlighted by the recent acquisition of LivePerson on September 4, 2026, aimed at integrating voice AI with enterprise digital messaging. The company launched its OASYS platform in Q2 2026, which is designed to unify voice and digital stacks for enterprises. SoundHound's CEO, Keyvan Mohajer, emphasized the importance of combining AI and human capabilities to enhance customer service across various industries, including financial services and healthcare, while also noting that the shift to on-device AI is expected to improve gross margins. https://openbell.ai/news/PS:1790684628252 2026-09-29T12:23:48.252Z daily 0.9 https://cdn.brandfetch.io/PS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jones Trading Downgrades Pershing Square to Hold Jones Trading analyst Jason Weaver has downgraded Pershing Square (NYSE: PS) from a 'Buy' rating to 'Hold'. This change reflects a shift in the firm's outlook on the stock's performance. https://openbell.ai/news/FDMT:1790684622035 2026-09-29T12:23:42.035Z daily 0.9 https://cdn.brandfetch.io/FDMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Maintains Buy on 4D Molecular Therapeutics, Raises Price Target to $33 B of A Securities analyst Tazeen Ahmad has maintained a 'Buy' rating on 4D Molecular Therapeutics (NASDAQ: FDMT) and increased the price target from $29 to $33. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/DMRA:1790684410819 2026-09-29T12:20:10.819Z daily 0.9 https://cdn.brandfetch.io/DMRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Damora Therapeutics, Maintains $40 Price Target Wedbush analyst David Nierengarten has reiterated an 'Outperform' rating on Damora Therapeutics (NASDAQ: DMRA) and has maintained a price target of $40 for the stock. https://openbell.ai/news/CBOE:1790684313680 2026-09-29T12:18:33.680Z daily 0.9 https://cdn.brandfetch.io/CBOE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cboe Global Markets, S&P Dow Jones Indices Extend Collaboration Through 2051 For Cboe To Provide Trading In Its S&P 500 Index Options Cboe Global Markets, Inc. (CBOE) and S&P Dow Jones Indices have extended their exclusive licensing agreement for an additional 25 years, continuing their collaboration through 2051. This agreement allows Cboe to maintain exclusive rights to trade its S&P 500 Index (SPX) options. The partnership may also explore innovations beyond traditional index derivatives, including potential new products like tokenized options contracts. https://openbell.ai/news/ACET:1790684276469 2026-09-29T12:17:56.469Z daily 0.9 https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Maintains Outperform on Adicet Bio, Raises Price Target to $28 Wedbush analyst Robert Driscoll has maintained an 'Outperform' rating on Adicet Bio (NASDAQ: ACET) and raised the price target from $25 to $28. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/NVTS:1790684248215 2026-09-29T12:17:28.215Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Navitas-Semiconductor-Corp-NASDAQNVTS.jpg?width=250&height=187 Navitas Stock Extends Gains After Army Selects It for SiC Power Chip Development Navitas Semiconductor Corporation (NASDAQ: NVTS) has been selected by the U.S. Army to develop next-generation 10 kV silicon carbide (SiC) power semiconductor technology under the ALATTIS program. This award highlights Navitas' leadership in ultra-high-voltage SiC innovation and its domestic manufacturing capabilities. Following the announcement, Navitas shares rose by 8.87% to $12.77. https://openbell.ai/news/MNSO:1790684183648 2026-09-29T12:16:23.648Z daily 0.9 https://cdn.brandfetch.io/MNSO/w/400/h/400?c=1idopYfmtR7ZKg8QMud MINISO Group CFO Jingjing Zhang Buys ~HK$2.7M Of Company Shares On The Open Market openbell Financial News https://openbell.ai/news/XNDU:1790684173216 2026-09-29T12:16:13.216Z daily 0.9 https://cdn.brandfetch.io/XNDU/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Initiates Coverage On Xanadu Quantum with Outperform Rating, Announces Price Target of $16 RBC Capital analyst Paul Treiber has initiated coverage on Xanadu Quantum (NASDAQ: XNDU) with an Outperform rating. The firm has set a price target of $16 for the stock. https://openbell.ai/news/YDDL:1790684091974 2026-09-29T12:14:51.974Z daily 0.9 https://cdn.brandfetch.io/YDDL/w/400/h/400?c=1idopYfmtR7ZKg8QMud One and one Green Techs H1 EPS $0.08 Up From $0.07 YoY, Sales $33.381M Up From $28.130M YoY One and one Green Techs (NASDAQ:YDDL) reported a first-half earnings per share (EPS) of $0.08, an increase of 14.29% from $0.07 in the same period last year. The company's sales reached $33.381 million, reflecting an 18.67% growth compared to $28.130 million in the prior year. https://openbell.ai/news/MU:1790683912243 2026-09-29T12:11:52.243Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Netlist Opens New Legal Proceedings At U.S. International Trade Commission Seeking Exclusion And Cease And Desist Orders Against Micron Technology And MU's Customers Nvidia, Broadcom And Google; Claims Infringement Of The Company's HBM Patents Netlist has initiated new legal proceedings at the U.S. International Trade Commission (ITC) against Micron Technology, seeking exclusion and cease-and-desist orders for alleged infringement of its HBM patents, specifically U.S. Patent Nos. 12,308,087 and 12,646,537. The complaint targets Micron's HBM3E, HBM4, and HBM4E products. This follows a previous ITC complaint filed by Netlist on August 11, 2026, which also involved other companies and alleged infringement of four additional patents related to Micron's DDR5 products. https://openbell.ai/news/HLSQ:1790683751149 2026-09-29T12:09:11.149Z daily 0.9 https://cdn.brandfetch.io/HLSQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tessera Defense and Homeland Security Expects FY27 Revenue Range Of $14M - $17M, $21M In FY28, And $30M In FY29 Tessera Defense and Homeland Security Inc. (NYSE: HLSQ) has announced its revenue targets for the upcoming years, projecting FY27 revenue between $14 million and $17 million, with expectations of $21 million in FY28 and $30 million in FY29. The company's growth strategy focuses on expanding its physical security platform through larger projects, new customers, and enhanced capabilities. https://openbell.ai/news/JNJ:1790683744020 2026-09-29T12:09:04.020Z daily 0.9 https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson & Johnson To Present New Findings On IMAAVY For Treatment Of Generalized Myasthenia Gravis Across 15 Novel Abstracts At 2026 MGFA Scientific Session And AANEM Annual Meeting Johnson & Johnson (NYSE: JNJ) announced new findings on IMAAVY (nipocalimab-aahu) for treating generalized myasthenia gravis (gMG), to be presented in 15 abstracts at the 2026 MGFA Scientific Session and AANEM Annual Meeting. The two-year Phase 2/3 study results in adolescents showed sustained disease control, improved daily function, increased muscle strength, and reduced corticosteroid use. Additionally, a retrospective survey highlighted fluctuating symptom control as a key factor for patients transitioning to IMAAVY from other treatments. https://openbell.ai/news/VOR:1790683672850 2026-09-29T12:07:52.850Z daily 0.9 https://cdn.brandfetch.io/VOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vor Bio Announces Data Phase 3 Trial Of Telitacicept By Its RemeGen Partner Demonstrates Over 95% Participants Achieved At Least 5-Point MG-ADL Improvement Over 48 Weeks Vor Bio (Nasdaq: VOR) announced a post hoc analysis from a Phase 3 trial conducted by its partner RemeGen, showing that over 95% of participants with generalized myasthenia gravis achieved at least a 5-point improvement on the MG-ADL scale over 48 weeks. The findings were presented at the MGFA Scientific Session during the 2026 AANEM Annual Meeting in Orlando, Florida. https://openbell.ai/news/ACXP:1790683660715 2026-09-29T12:07:40.715Z daily 0.9 https://cdn.brandfetch.io/ACXP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Acurx Pharmaceuticals Says First Patient Enrolled In New PATHFINDER Clinical Trial In Patients With Multiply Recurrent C. Difficile Infection Acurx Pharmaceuticals has enrolled the first patient in its PATHFINDER Phase 2 clinical trial, which evaluates the efficacy and safety of ibezapolstat for treating multiply recurrent C. difficile infection (rCDI). This pilot trial will involve approximately 20 patients and aims to support a U.S. New Drug Application (NDA) based on a subsequent Phase 3 trial. Acurx is also preparing for its ASPIRE Phase 3 trial, which will compare ibezapolstat to standard care, pending funding availability. The company has received FDA QIDP and Fast-Track Designation, as well as SME designation from the EMA. https://openbell.ai/news/RTX:1790683649793 2026-09-29T12:07:29.793Z daily 0.9 https://cdn.brandfetch.io/RTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raytheon Selects Lyntris To Support Multi-Year LTAMDS Radar Production Raytheon has selected Lyntris to support the multi-year production of the LTAMDS radar under a long-term purchase agreement. This partnership reinforces Lyntris' role in enhancing integrated air and missile defense capabilities. The financial terms of the agreement were not disclosed. https://openbell.ai/news/CAT:1790683634435 2026-09-29T12:07:14.435Z daily 0.9 https://cdn.brandfetch.io/CAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Caterpillar To Acquire The Fabick Chain Of Equipment Dealers With A Presence Across Four Midwestern States; Terms Not Disclosed Caterpillar has announced its intention to acquire the John Fabick Tractor Company, a long-standing dealer with over 100 years of service across Missouri, Illinois, Wisconsin, and Michigan. The acquisition aims to ensure a smooth transition of ownership while maintaining customer service. The deal is pending regulatory approval and is expected to close within 30 days. Financial terms of the acquisition have not been disclosed. https://openbell.ai/news/ALK:1790683619776 2026-09-29T12:06:59.776Z daily 0.9 https://cdn.brandfetch.io/ALK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alaska Air President Tackett Tells Reuters Premium Investments Could Eventually Add $3.00-$4.00/Share To Earnings openbell Financial News https://openbell.ai/news/BBGI:1790683580689 2026-09-29T12:06:20.689Z daily 0.9 https://cdn.brandfetch.io/BBGI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beasley Broadcast Group Announces $5M Registered Direct Offering Priced At $14 Per Share, Concurrent Private Placement Warrants To Purchase 357,000 Shares Beasley Broadcast Group, Inc. (NASDAQ: BBGI) has announced a $5 million registered direct offering priced at $14 per share for 357,000 shares of Class A Common Stock. Concurrently, the company will issue unregistered warrants to purchase an equal number of shares at an exercise price of $15. The proceeds will be used to reduce borrowings under its revolving credit facility and to redeem a portion of its 11.000% Senior Secured First Lien Notes due 2028. The closing of the offering is expected around September 30, 2026, pending customary closing conditions. https://openbell.ai/news/FFAI:1790683560493 2026-09-29T12:06:00.493Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, Faraday Future (NASDAQ: FFAI) shares rose by 13.5% to $1.6, with a market cap of $8.6 million. Ark Restaurants (NASDAQ: ARKR) and EpicQuest Education Group (NASDAQ: EEIQ) also saw significant gains of 9.48% and 8.73%, respectively. Conversely, Neo-Concept Intl Group Hldgs (NASDAQ: NCI) experienced a sharp decline of 43.3%, bringing its stock price down to $1.35 and its market cap to $6.1 million. https://openbell.ai/news/SLXN:1790683560005 2026-09-29T12:06:00.005Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Health Care Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, Silexion Therapeutics (NASDAQ: SLXN) saw a significant increase of 26.8% to $0.32, with a market cap of $1.3 million. Other notable gainers included Summit Therapeutics (NASDAQ: SMMT), which rose 16.34% to $18.01, and Iovance Biotherapeutics (NASDAQ: IOVA), which increased by 10.55% to $12.15. Conversely, NewGenIvf Group (NASDAQ: NIVF) experienced a sharp decline of 67.6% to $0.11, while uniQure (NASDAQ: QURE) fell 55.92% to $17.24, resulting in a market cap of $2.7 billion. https://openbell.ai/news/SLND:1790683559762 2026-09-29T12:05:59.762Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Industrials Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, Southland Holdings (AMEX: SLND) shares surged by 54.5% to $0.94, with a market cap of $33.2 million. Other notable gainers included Masonglory (NASDAQ: MSGY), up 15.97% to $3.63, and Voyager Technologies (NYSE: VOYG), which rose 12.71% to $37.4, bringing its market cap to $2.0 billion. Conversely, Julong Holding (NASDAQ: JLHL) experienced a significant drop of 30.1% to $4.14, while Enigmatig (AMEX: EGG) fell by 15.3% to $3.6. https://openbell.ai/news/BKYI:1790683559584 2026-09-29T12:05:59.584Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, BIO-key International (NASDAQ: BKYI) saw a significant stock increase of 56.0%, reaching $2.62, with a market cap of $2.4 million. Other notable gainers included SoundThinking (NASDAQ: SSTI) up 49.17% to $8.16, and Sangoma Technologies (NASDAQ: SANG) rising 38.99% to $4.99. Conversely, CID Holdco (NASDAQ: DAIC) experienced the largest decline, dropping 18.7% to $2.65, following the release of its Q2 earnings. https://openbell.ai/news/HOOD:1790683551129 2026-09-29T12:05:51.129Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/29/Dhaka--Bangladesh--18-March-2025-Robinho.jpg?width=250&height=187 Robinhood To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday BTIG raised the price target for Robinhood Markets, Inc. (NASDAQ: HOOD) from $125 to $135, maintaining a Buy rating. Robinhood shares closed at $116.46 on Monday, indicating a potential rally of approximately 16%. This adjustment reflects a positive outlook from analysts amidst broader market evaluations. https://openbell.ai/news/PHAT:1790683550409 2026-09-29T12:05:50.409Z daily 0.9 https://cdn.brandfetch.io/PHAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phathom Pharmaceuticals Initiates Registrational Phase 3 Study Of VOQUEZNA For As-Needed Treatment Of Non-Erosive GERD Phathom Pharmaceuticals has initiated a registrational Phase 3 study of VOQUEZNA (vonoprazan) for as-needed treatment of Non-Erosive Reflux Disease (NERD), following positive Phase 2 data. The study, named pHalcon-NERD-302, aims to support a potential label expansion for VOQUEZNA to treat heartburn episodes in patients with Non-Erosive GERD, a regimen not currently approved for proton pump inhibitors in the U.S. Topline results from the study are expected in the first quarter of 2028.